219 related articles for article (PubMed ID: 26344651)
1. Anti-PLA2R Antibodies as a Prognostic Factor in PLA2R-Related Membranous Nephropathy.
Timmermans SA; Abdul Hamid MA; Cohen Tervaert JW; Damoiseaux JG; van Paassen P;
Am J Nephrol; 2015; 42(1):70-7. PubMed ID: 26344651
[TBL] [Abstract][Full Text] [Related]
2. Association of anti-PLA₂R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy.
Bech AP; Hofstra JM; Brenchley PE; Wetzels JF
Clin J Am Soc Nephrol; 2014 Aug; 9(8):1386-92. PubMed ID: 25035272
[TBL] [Abstract][Full Text] [Related]
3. Primary Membranous Nephropathy.
Couser WG
Clin J Am Soc Nephrol; 2017 Jun; 12(6):983-997. PubMed ID: 28550082
[TBL] [Abstract][Full Text] [Related]
4. Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy.
Stefan G; Stancu S; Zugravu A; Popa O; Zubidat D; Petre N; Mircescu G
Ren Fail; 2022 Dec; 44(1):258-268. PubMed ID: 35172682
[TBL] [Abstract][Full Text] [Related]
5. Phospholipase-A2 receptor antibody, 24 hours proteinuria, and serum albumin as indicators of cyclophosphamide efficacy in idiopathic membranous nephropathy.
Xiao C; Liu Y; Zhang X; Luo L; Li X; Wang T; Tian Z; Qin X; Liu J
J Clin Lab Anal; 2020 Sep; 34(9):e23368. PubMed ID: 32449206
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological Characteristics and Outcomes of PLA
Luo J; Yuan Y; Tian J; Zhou Z; Su C; Yang F; Wang G
Am J Kidney Dis; 2022 Sep; 80(3):364-372. PubMed ID: 35288217
[TBL] [Abstract][Full Text] [Related]
7. Combined Serologic and Genetic Risk Score and Prognostication of Phospholipase A2 receptor-Associated Membranous Nephropathy.
Hu X; Xu J; Wang W; Liu L; Jing Y; Gao C; Yu X; Li Y; Lin L; Tong J; Weng Q; Pan X; Zhang W; Ren H; Li G; Kiryluk K; Chen N; Xie J
Clin J Am Soc Nephrol; 2024 May; 19(5):573-582. PubMed ID: 38423528
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen-albumin ratio predicts treatment response in phospholipase A2 receptor-associated membranous nephropathy with nephrotic syndrome.
Duan S; Chen S; Chen C; Lu F; Pan Y; Lu Y; Li Q; Liu S; Zhang B; Mao H; Xing C; Yuan Y
Ren Fail; 2024 Dec; 46(1):2359024. PubMed ID: 38832491
[TBL] [Abstract][Full Text] [Related]
9. A Proposal for a Serology-Based Approach to Membranous Nephropathy.
De Vriese AS; Glassock RJ; Nath KA; Sethi S; Fervenza FC
J Am Soc Nephrol; 2017 Feb; 28(2):421-430. PubMed ID: 27777266
[TBL] [Abstract][Full Text] [Related]
10. The application of podocyte antigen PLA2R and anti-PLA2R antibody in the diagnosis and treatment of membranous nephropathy.
Chen Y; Xu Y; Chen S; Yu Y; Zhu X; Chen J
Ren Fail; 2023; 45(2):2264939. PubMed ID: 37814415
[TBL] [Abstract][Full Text] [Related]
11. Membranous nephropathy in patients with HIV: a report of 11 cases.
Charu V; Andeen N; Walavalkar V; Lapasia J; Kim JY; Lin A; Sibley R; Higgins J; Troxell M; Kambham N
BMC Nephrol; 2020 Sep; 21(1):401. PubMed ID: 32948130
[TBL] [Abstract][Full Text] [Related]
12. Effect of Glomerular Mannose-Binding Lectin Deposition on the Prognosis of Idiopathic Membranous Nephropathy.
Zhang Y; Liu Y; Liang L; Liu L; Tang X; Tang L; Chen P; Chen J; Wang Z; Cao W; Chen Q; Zhao N; Xu D
Kidney Blood Press Res; 2020; 45(5):713-726. PubMed ID: 32894840
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of the domain specific PLA2R antibodies for clinical remission in patients with primary membranous nephropathy: A retrospective study.
Zhou K; Zhou J; Zhou L; Xue J; Liu B; Zhang Z; Zhang X; Cai T; Shao S; Huang B; Zhang Y; Hu Z; Wang L; Liu X
PLoS One; 2024; 19(5):e0302100. PubMed ID: 38718066
[TBL] [Abstract][Full Text] [Related]
14. Phospholipase A2 Receptor Antibodies and Clinical Prognosis in Patients with Idiopathic Membranous Nephropathy: An Updated Systematic Review and Meta-Analysis.
Zhang J; Fan Z; Wang P; Zhang AH
Kidney Blood Press Res; 2023; 48(1):102-113. PubMed ID: 36720217
[TBL] [Abstract][Full Text] [Related]
15. Combination of Rituximab, Low-Dose Cyclophosphamide, and Prednisone for Primary Membranous Nephropathy: A Case Series With Extended Follow Up.
Zonozi R; Laliberte K; Huizenga NR; Rosenthal JK; Jeyabalan A; Collins AB; Cortazar FB; Niles JL
Am J Kidney Dis; 2021 Dec; 78(6):793-803. PubMed ID: 34174365
[TBL] [Abstract][Full Text] [Related]
16. Primary antiphospholipid syndrome associated with anti-phospholipase A2 receptor antibody-positive membranous nephropathy.
Teisseyre M; Perrochia H; Reboul P; Cariou S; Renaud S; Aglae C; Moranne O
BMC Nephrol; 2020 May; 21(1):196. PubMed ID: 32448215
[TBL] [Abstract][Full Text] [Related]
17. Sjögren's syndrome complicated with membranous nephropathy, a cause or coincidence?
Chen R; Wang J; Xie Q; Xue J; Hao C
Int J Rheum Dis; 2021 Aug; 24(8):1086-1094. PubMed ID: 34223708
[TBL] [Abstract][Full Text] [Related]
18. Retrospective analysis of
Guo Y; Guo N; Wang J; Wang R; Tang L
Ren Fail; 2021 Dec; 43(1):729-736. PubMed ID: 33904354
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of primary membranous nephropathy based on serum anti-phospholipase A2 receptor antibodies and glomerular phospholipase A2 receptor antigen status: a retrospective cohort study.
Yin P; Wang J; Liang W; Zhan L; Liu Y; Lin J; Chen X; He Y; Jian H; Xie Z; Tan X; Ye Q; Huang F
Ren Fail; 2020 Nov; 42(1):675-683. PubMed ID: 32674643
[TBL] [Abstract][Full Text] [Related]
20. Effects of hydroxychloroquine on proteinuria in membranous nephropathy.
Cheng YJ; Cheng XY; Zhang YM; Wang F; Wang X; Meng LQ; Liu G; Cui Z; Zhao MH
J Nephrol; 2022 May; 35(4):1145-1157. PubMed ID: 34846713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]